We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
The current JAGX market cap is 8.21M. The company's latest EPS is USD -0.8137 and P/E is -0.21.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 3.15M | 3.26M | 1.97M | 2.68M | 2.81M |
| Operating Income | -9.9M | -6.29M | -9.85M | -8.1M | -8.79M |
| Net Income | -12.52M | -7.58M | -12.2M | -12.15M | -7.78M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 5.78M | 9.39M | 4.34M | 11.96M | 9.76M |
| Operating Income | -28.95M | -26.65M | -40.71M | -34.42M | -34.29M |
| Net Income | -44.73M | -38.65M | -52.6M | -47.45M | -41.3M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 51.29M | 47.45M | 56.93M | 52.17M | 45.38M |
| Total Liabilities | 47.69M | 48.81M | 49.27M | 46.34M | 43.96M |
| Total Equity | 3.6M | -1.36M | 7.66M | 5.83M | 1.42M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 36.41M | 42.84M | 53.27M | 47.45M | 50.76M |
| Total Liabilities | 15.84M | 25.64M | 41.41M | 48.81M | 45.87M |
| Total Equity | 10.67M | 17.2M | 11.85M | -1.36M | 4.9M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -26.68M | -33.1M | -9.95M | -19M | -25.79M |
| Investing | -1.31M | -1.68M | N/A | N/A | N/A |
| Financing | 21.54M | 23.18M | 18.81M | 22.17M | 23.58M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -20.46M | -15.28M | -34.97M | -33.1M | -33.24M |
| Investing | N/A | -7k | -6k | -1.68M | N/A |
| Financing | 21.77M | 19.49M | 43.94M | 23.18M | 34.23M |
| Market Cap | 8.21M |
| Price to Earnings Ratio | -0.21 |
| Price to Sales Ratio | 0.88 |
| Price to Cash Ratio | 1.33 |
| Price to Book Ratio | 1.76 |
| Dividend Yield | - |
| Shares Outstanding | 50.76M |
| Average Volume (1 week) | 173.51M |
| Average Volume (1 Month) | 85.26M |
| 52 Week Change | -74.34% |
| 52 Week High | 1.22 |
| 52 Week Low | 0.0512 |
| Spread (Intraday) | 0 (0.43%) |
| Company Name | Jaguar Health Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://jaguar.health |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
